Erlend B. Smeland

24.8k total citations
155 papers, 5.4k citations indexed

About

Erlend B. Smeland is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Erlend B. Smeland has authored 155 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 56 papers in Immunology and 48 papers in Oncology. Recurrent topics in Erlend B. Smeland's work include Lymphoma Diagnosis and Treatment (40 papers), T-cell and B-cell Immunology (27 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Erlend B. Smeland is often cited by papers focused on Lymphoma Diagnosis and Treatment (40 papers), T-cell and B-cell Immunology (27 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Erlend B. Smeland collaborates with scholars based in Norway, United States and Sweden. Erlend B. Smeland's co-authors include Heidi Kiil Blomhoff, Klaus Beiske, June H. Myklebust, Harald Holte, Steinar Funderud, Trond Stokke, S. Funderud, Jon Lømo, Tore Godal and Sten Eirik W. Jacobsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Erlend B. Smeland

154 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erlend B. Smeland Norway	45	2.4k	2.0k	1.5k	998	575	155	5.4k
Cornelis L. Verweij Netherlands	34	2.4k 1.0×	2.0k 1.0×	1.4k 1.0×	660 0.7×	433 0.8×	62	6.1k
Kurt Bommert Germany	35	3.1k 1.3×	1.2k 0.6×	1.8k 1.2×	979 1.0×	573 1.0×	65	5.1k
Ronald Herbst United States	39	2.4k 1.0×	2.8k 1.4×	2.0k 1.4×	647 0.6×	241 0.4×	130	6.5k
Walter C. Darbonne United States	26	2.7k 1.1×	1.5k 0.8×	1.9k 1.3×	407 0.4×	1.4k 2.4×	46	6.1k
Alessandra Cesano United States	34	1.0k 0.4×	1.6k 0.8×	1.7k 1.2×	598 0.6×	544 0.9×	172	4.1k
Domenico Delia Italy	43	4.2k 1.7×	950 0.5×	2.5k 1.7×	673 0.7×	438 0.8×	125	6.9k
JC Reed United States	20	4.0k 1.6×	1.0k 0.5×	1.7k 1.1×	854 0.9×	280 0.5×	31	6.0k
David Spaner Canada	35	1.4k 0.6×	1.8k 0.9×	1.9k 1.3×	954 1.0×	554 1.0×	123	4.7k
Matthew L. Sherman United States	41	3.2k 1.3×	2.2k 1.1×	2.1k 1.5×	448 0.4×	1.5k 2.7×	134	7.8k
Marianne T. Sweetser United States	31	2.1k 0.9×	2.2k 1.1×	1.2k 0.8×	2.2k 2.3×	399 0.7×	76	6.2k

Countries citing papers authored by Erlend B. Smeland

Since Specialization

Citations

This map shows the geographic impact of Erlend B. Smeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erlend B. Smeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erlend B. Smeland more than expected).

Fields of papers citing papers by Erlend B. Smeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erlend B. Smeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erlend B. Smeland. The network helps show where Erlend B. Smeland may publish in the future.

Co-authorship network of co-authors of Erlend B. Smeland

This figure shows the co-authorship network connecting the top 25 collaborators of Erlend B. Smeland. A scholar is included among the top collaborators of Erlend B. Smeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erlend B. Smeland. Erlend B. Smeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huse, Kanutte, Baoyan Bai, Thea Kristin Våtsveen, et al.. (2022). Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression. The Journal of Immunology. 209(10). 2042–2053. 32 indexed citations

Rusten, Leiv Sindre, Marit Slaaen, Erlend B. Smeland, et al.. (2021). A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL. Blood Advances. 5(22). 4771–4782. 17 indexed citations

Beiske, Klaus, Yngvild Nuvin Blaker, Harald Holte, et al.. (2019). TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma. Cancer Immunology Research. 7(3). 355–362. 82 indexed citations

Huse, Kanutte, Hannah G. Polikowsky, Kirsten E. Diggins, et al.. (2019). Human Germinal Center B Cells Differ from Naïve and Memory B Cells in CD40 Expression and CD40L‐Induced Signaling Response. Cytometry Part A. 95(4). 442–449. 9 indexed citations

Köksal, Hakan, Pierre Dillard, Sólrún Melkorka Maggadóttir, et al.. (2019). Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood Advances. 3(8). 1230–1243. 39 indexed citations

Huse, Kanutte, Arne Kolstad, Klaus Beiske, et al.. (2017). T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling. Clinical Cancer Research. 24(4). 870–881. 76 indexed citations

Hystad, Marit E., June H. Myklebust, Trond Hellem Bø, et al.. (2009). Characterization of early stages of human B cell development by gene expression profiling. The Journal of Immunology. 182(9). 5882–5882. 6 indexed citations

Hystad, Marit E., June H. Myklebust, Trond Hellem Bø, et al.. (2007). Characterization of Early Stages of Human B Cell Development by Gene Expression Profiling. The Journal of Immunology. 179(6). 3662–3671. 115 indexed citations

Lenz, Georg, Inga Nagel, Reiner Siebert, et al.. (2007). Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma. The Journal of Experimental Medicine. 204(3). 633–643. 139 indexed citations

10.

Sivertsen, Einar Andreas, Marit E. Hystad, Kristine B. Gützkow, et al.. (2006). PI3K/Akt‐dependent Epo‐induced signalling and target genes in human early erythroid progenitor cells. British Journal of Haematology. 135(1). 117–128. 34 indexed citations

11.

Fosså, Alexander, Reiner Siebert, Gunhild M. Mælandsmo, et al.. (2000). Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer. British Journal of Cancer. 83(6). 743–749. 28 indexed citations

12.

Ly, Bao Chau, et al.. (1998). Kronisk lymfatisk leukemi. Tidsskrift for Den Norske Laegeforening.

13.

Hořejšı́, Václav, Finn Olav Levy, Erlend B. Smeland, et al.. (1997). CDw78 — a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton. European Journal of Immunology. 27(12). 3206–3213. 11 indexed citations

14.

Kvalheim, Gunnar, Anne Pharo, Harald Holte, et al.. (1996). Purging of Tumor Cells from Leukapheresis Products: Experimental and Clinical Aspects. Journal of Hematotherapy. 5(4). 427–436. 26 indexed citations

15.

Jacobsen, Sten Eirik W., C Fahlman, Heidi Kiil Blomhoff, et al.. (1994). All-trans- and 9-cis-retinoic acid: potent direct inhibitors of primitive murine hematopoietic progenitors in vitro.. The Journal of Experimental Medicine. 179(5). 1665–1670. 32 indexed citations

16.

Erikstein, Björn, Harald Holte, Stein Kvaløy, et al.. (1993). Expression of CD18 (integrin β₂ chain) correlates with prognosis in malignant B cell lymphomas. British Journal of Haematology. 83(3). 392–398. 11 indexed citations

17.

Lømo, Jon, et al.. (1991). Differential Effects of Interferon‐γ and Low Molecular Weight BCGF on Growth of Human B Lymphocytes; Interferon‐γ Prolongs the Increased c‐MYC mRNA Levels After Activation. Scandinavian Journal of Immunology. 33(4). 365–373. 3 indexed citations

18.

Stamenkovic, Ivan, et al.. (1990). The B cell antigen CD75 is a cell surface sialytransferase.. The Journal of Experimental Medicine. 172(2). 641–643. 55 indexed citations

19.

Smeland, Erlend B., et al.. (1989). Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes.. The Journal of Experimental Medicine. 170(4). 1463–1468. 78 indexed citations

20.

Holte, Harald, Catharina de Lange Davies, Klaus Beiske, et al.. (1989). Ki67 and 4F2 antigen expression as well as dna synthesis predict survival at relapse/tumour progression in low‐grade B‐cell lymphoma. International Journal of Cancer. 44(6). 975–980. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact